1. Home
  2. RLMD vs MXC Comparison

RLMD vs MXC Comparison

Compare RLMD & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • MXC
  • Stock Information
  • Founded
  • RLMD 2004
  • MXC 1972
  • Country
  • RLMD United States
  • MXC United States
  • Employees
  • RLMD N/A
  • MXC N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • RLMD Health Care
  • MXC Energy
  • Exchange
  • RLMD Nasdaq
  • MXC Nasdaq
  • Market Cap
  • RLMD 11.5M
  • MXC 13.3M
  • IPO Year
  • RLMD N/A
  • MXC N/A
  • Fundamental
  • Price
  • RLMD $0.40
  • MXC $7.00
  • Analyst Decision
  • RLMD Hold
  • MXC
  • Analyst Count
  • RLMD 4
  • MXC 0
  • Target Price
  • RLMD $4.25
  • MXC N/A
  • AVG Volume (30 Days)
  • RLMD 4.5M
  • MXC 3.1K
  • Earning Date
  • RLMD 05-12-2025
  • MXC 06-26-2025
  • Dividend Yield
  • RLMD N/A
  • MXC 2.98%
  • EPS Growth
  • RLMD N/A
  • MXC N/A
  • EPS
  • RLMD N/A
  • MXC 0.63
  • Revenue
  • RLMD N/A
  • MXC $7,161,739.00
  • Revenue This Year
  • RLMD N/A
  • MXC N/A
  • Revenue Next Year
  • RLMD N/A
  • MXC N/A
  • P/E Ratio
  • RLMD N/A
  • MXC $10.41
  • Revenue Growth
  • RLMD N/A
  • MXC 2.12
  • 52 Week Low
  • RLMD $0.24
  • MXC $5.89
  • 52 Week High
  • RLMD $4.47
  • MXC $14.11
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.73
  • MXC 50.94
  • Support Level
  • RLMD $0.36
  • MXC $6.41
  • Resistance Level
  • RLMD $0.44
  • MXC $6.97
  • Average True Range (ATR)
  • RLMD 0.08
  • MXC 0.35
  • MACD
  • RLMD -0.00
  • MXC 0.13
  • Stochastic Oscillator
  • RLMD 26.98
  • MXC 84.30

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: